CONMED Corporation (CNMD)
Profitability ratios
Return on sales
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Gross profit margin | 54.33% | 54.64% | 56.21% | 53.37% | 54.94% |
| Operating profit margin | 9.69% | 6.70% | 10.86% | 5.33% | 8.28% |
| Pretax margin | 6.49% | -6.78% | 7.23% | 0.19% | 3.27% |
| Net profit margin | 5.18% | -7.71% | 6.19% | 1.10% | 3.00% |
Conmed Corp.'s profitability ratios have shown varying trends over the past five years.
1. Gross Profit Margin: Conmed Corp.'s gross profit margin has remained relatively stable in the range of 53.37% to 56.21% over the five-year period. This indicates the company's ability to efficiently manage production costs and generate profits from its core operations.
2. Operating Profit Margin: The operating profit margin has fluctuated between 5.33% and 10.86% during the same period. The increase in 2021 compared to 2020 could indicate improved operational efficiency, while the decrease in 2022 suggests potential challenges in controlling operating expenses.
3. Pretax Margin: Conmed Corp.'s pretax margin has shown significant fluctuations, ranging from a negative figure in 2022 to a peak of 7.23% in 2021. The negative pretax margin in 2022 indicates that the company's pre-tax profitability was impacted by certain costs exceeding its pre-tax income.
4. Net Profit Margin: The net profit margin also varied notably, with a negative margin in 2022 and a significant increase in 2023. The negative net profit margin in 2022 could be due to extraordinary expenses or one-time charges that affected the company's bottom line.
In summary, Conmed Corp.'s overall profitability, as measured by these margins, has experienced ups and downs over the past five years. It is important for the company to closely monitor its cost structure, revenue streams, and efficiency in order to sustain and improve its profitability in the future.
Return on investment
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 5.24% | 3.05% | 6.21% | 2.63% | 4.46% |
| Return on assets (ROA) | 2.80% | -3.51% | 3.54% | 0.54% | 1.61% |
| Return on total capital | 14.46% | -5.63% | 13.83% | 6.44% | 10.41% |
| Return on equity (ROE) | 7.73% | -10.81% | 7.96% | 1.34% | 4.03% |
Conmed Corp.'s profitability ratios have shown fluctuating trends over the past five years. The operating return on assets (Operating ROA) improved from 2019 to 2021, indicating the company's efficiency in generating operating profits from its assets. However, there was a slight decline in 2023 compared to 2021.
Return on assets (ROA) was negative in 2022, indicating that the company did not generate profit from its assets during that year. Nevertheless, there was a significant improvement in 2023, with a positive ROA of 2.80%.
Return on total capital and return on equity (ROE) followed a similar pattern, with an increase from 2019 to 2021, indicating better returns generated on both total capital and equity. However, there was a slight decrease in 2023 compared to 2021 for both ratios.
Overall, Conmed Corp. has shown mixed profitability performance over the past five years, with improvements in some areas but fluctuations in others. Monitoring these ratios will be crucial for assessing the company's financial health and performance in the future.